Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		Erlotinib (Tarceva) Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma

		Keywords:		Tarceva

		Phase:		Phase 1

		Treatment ID#s:		VT1759 NCT00360854

		Age Group:		Pediatric Only

		Min Karnofsky Score:		50: Requires considerable assistance and frequent medical care

		Conditions:		Newly Diagnosed: Y Recurrent: Y Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed

		Last Updated:		04/15/2007

		Tumor Types:		Brainstem Glioma Pediatric Brain Tumors


		Comments:		This phase I trial is studying the side effects and best dose of erlotinib when given alone or together with radiation therapy in treating young patients with refractory or relapsed malignant brain tumors or newly diagnosed brain stem glioma.

		Treatment Type:		Radiation Less-Toxics.

		Contact:		Our Lady`s Hospital for Sick Children Crumlin Fin Breatnach, MD, FRCPE Dublin, Ireland Phone:353-1-409-6659 Click here to send an email

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2010 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By